CLINICAL_TRIALS
trial_result
· 2023-06-15
Clinical Trial Update: Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus [Phase 2]
Summary
Phase 2 clinical trial evaluating docetaxel plus carboplatin in advanced esophageal cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eastern Cooperative Oncology Group | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED